Skip to main content
John Pagel, MD, Oncology, Seattle, WA, UW Medicine/University of Washington Medical Center

JohnMichaelPagelMD

Oncology Seattle, WA

Associate Professor, Medicine, University of Washington School of Medicine

Are you Dr. Pagel?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 45 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. John Pagel, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and California. He is affiliated with Swedish First Hill Campus and UW Medicine/University of Washington Medical Center.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1999 - 2002
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - Present
  • WA State Medical License
    WA State Medical License 1999 - 2026

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Actinium Pharmaceuticals Applauds CancerCare® for Launching the First Ever Acute Myeloid Leukemia Awareness Month
    Actinium Pharmaceuticals Applauds CancerCare® for Launching the First Ever Acute Myeloid Leukemia Awareness MonthJune 2nd, 2016

Grant Support

  • Bone Marrow Transplantation For Hematologic Malignancies Using Novel RadioimmunotNational Cancer Institute2010–2012
  • Radioimmunotherapy For LeukemiaNational Cancer Institute2011
  • Radioimmunotherapy Of CD20+ Lymphomas &Cd45+LeukemiasNational Cancer Institute2004–2008
  • Radiolabeled Bc8, Flu, TBI And PBSC Transplant For Elderly AML Or MDS PatientsNational Center For Research Resources2006–2007
  • Radiolabeled Bc8, Fludarabine, TBI Followed By PBSC Transplant For Advanced AMLNational Center For Research Resources2006
  • Radiolabeled Bc8 (Anti-Cd45) Antibody Treatment For Acute Myeloid LeukemiaNational Center For Research Resources2005
  • Phase I Study: Elderly Patients With Myeloid Leukemia Or Myelodysplastic SyndromNational Center For Research Resources2005
  • A Feasibility Trial Combining Radiolabeled Bc8 Antibody With FludarabineNational Center For Research Resources2005
  • Phase II Study For Acute Myelogenous Leukemia In FirstNational Center For Research Resources2004

Professional Memberships

Hospital Affiliations